Details

NameSymbolSector
SAMRAT PHARMACHEM LTD.SAMRATPHPharmaceuticals
Open
238.8
High
254.2
Low
237
Close
254.2
Volume
9266
Exchange
bse
Time
16-Oct-2026

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Samrat Pharmachem is  
Closing Marubozu
Estimated Stoploss of Samrat Pharmachem is ₹  
237
Samrat Pharmachem has a  
Bullishℹ
 pattern. 
Formation of  
Closing Marubozu
 candle pattern indicates Samrat Pharmachem has chances of  
Continuationℹ
 of the current trend. 

Trend

Samrat Pharmachem is in  
Sideways trendℹ
. 
Price of Samrat Pharmachem is  
Upℹ
 by  

6.88

%. 
Target
Buy @ 

216.06

Sell @ 

268.5

Current @ 

254.2

Volume

The trades of Samrat Pharmachem have been in  
Immenseℹ
 volume. 
The volume trades for Samrat Pharmachem are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Samrat Pharmachem is  

Up

 by  

328.66

% 

Valuation

The current market price of Samrat Pharmachem is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 121cr and total assets worth ₹ 121cr, the balance sheet of Samrat Pharmachem is:  
Balancedℹ
. 
Cashflow
Samrat Pharmachem has  
Badℹ
 cash flow because there is  

Shortage

 of  

₹ 9cr

. It is  
Downℹ
 by  

350

%. 

(*Mar 2025)

100% i.e. ₹ 10cr spent in operatingℹ
0% in investingℹ
0% in financingℹ
0% in otherℹ
Samrat Pharmachem has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

45% i.e. ₹ 9cr earned in operatingℹ
0% in investingℹ
55% i.e. ₹ 11cr spent in financingℹ
0% in otherℹ
Income
The income of Samrat Pharmachem is  

₹ 78cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Samrat Pharmachem Losses increased by:  

0

% and Income is Up by:  

2.63

% 

(*Sep 2025)

The income of Samrat Pharmachem is  

₹ 76cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Samrat Pharmachem Losses increased by:  

0

% and Income is Up by:  

7.04

% 

(*Jun 2025)

The income of Samrat Pharmachem is  

₹ 71cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Samrat Pharmachem Losses increased by:  

100

% and Income is Up by:  

12.7

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.